ConductScience.org, home

Paper41220940

A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America.

Chiang CL and 9 others. Front Oncol, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America. Papers, record 41220940. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41220940

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America.
PubMed
Journal
Front Oncol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-11-14
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chiang CLChi-Lu
2Soo RARoss Andrew
3Mok TTony
4Voon PJPei Jye
5Thamlikitkul LLucksamon
6Cheng YYing
7Horinouchi HHidehito
8Cho BCByong Chul
9Xu KLKrista Lin
10Ahn MJMyung-Ju

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References107

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133828968Treatment Outcomes of 9,994 Patients With Extensive-Disease Small-Cell Lung Cancer From a Retrospective Nationwide Population-Based Cohort in the Korean HIRA Database.Front Oncol2021https://conductscience.org/library/papers/33828968PubMed
238992123Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nat Med2024https://conductscience.org/library/papers/38992123PubMed
333864941Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆.Ann Oncol2021https://conductscience.org/library/papers/33864941PubMed
439268857Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer.N Engl J Med2024https://conductscience.org/library/papers/39268857PubMed
533492362Race and Pharmacogenomics-Personalized Medicine or Misguided Practice?JAMA2021https://conductscience.org/library/papers/33492362PubMed
621714641Reduced lung-cancer mortality with low-dose computed tomographic screening.N Engl J Med2011https://conductscience.org/library/papers/21714641PubMed
724828667Small-cell lung cancers in patients who never smoked cigarettes.J Thorac Oncol2014https://conductscience.org/library/papers/24828667PubMed
829770597Comparison and discussion of the treatment guidelines for small cell lung cancer.Thorac Cancer2018https://conductscience.org/library/papers/29770597PubMed
937037178Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy.Lung Cancer2023https://conductscience.org/library/papers/37037178PubMed
1037150311Novel therapeutic strategies for recurrent SCLC.Crit Rev Oncol Hematol2023https://conductscience.org/library/papers/37150311PubMed
1137504325Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer.Curr Oncol2023https://conductscience.org/library/papers/37504325PubMed
1234047192Race and ethnicity representation in clinical trials: findings from a literature review of Phase I oncology trials.Future Oncol2021https://conductscience.org/library/papers/34047192PubMed
1332959954Prognostic value of pretreatment smoking status for small cell lung cancer: A meta-analysis.Thorac Cancer2020https://conductscience.org/library/papers/32959954PubMed
1437054974Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance.Mod Pathol2023https://conductscience.org/library/papers/37054974PubMed
1537460438[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition)].Zhonghua Zhong Liu Za Zhi2023https://conductscience.org/library/papers/37460438PubMed
1635220975Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC).World J Surg Oncol2022https://conductscience.org/library/papers/35220975PubMed
1737098228Tarlatamab: New Star on the Horizon for Small-Cell Lung Cancer?J Clin Oncol2023https://conductscience.org/library/papers/37098228PubMed
1817450263Survival of small-cell lung cancer and its determinants of outcome in Singapore.Ann Acad Med Singap2007https://conductscience.org/library/papers/17450263PubMed
1933245986Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited-stage after surgery.Hum Pathol2021https://conductscience.org/library/papers/33245986PubMed
2034902832Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2021https://conductscience.org/library/papers/34902832PubMed

See all 107 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42762420Tarlatamab in small cell lung cancer following platinum-based chemotherapy: subgroup analysis of Japanese patients from the DeLLphi-304 study.Int J Clin Oncol2026https://conductscience.org/library/papers/42762420PubMed
42366584Diagnostic Value of CCL2 and CCR2 in Pleural Effusion for Distinguishing Lung Cancer Histological Subtypes: A Retrospective Study.Diagn Cytopathol2026https://conductscience.org/library/papers/42366584PubMed
42183205Case Report: Neuroendocrine-marker-negative high-grade neuroendocrine carcinoma mimicking squamous cell carcinoma: an underrecognized diagnostic pitfall.Front Immunol2026https://conductscience.org/library/papers/42183205PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41220940

GET https://conductscience.org/api/papers/v1/41220940/references?page=2